CTL response following combination therapy with NDV. by Hedieh Zargaran (21410233)

<b> </b> Spatial memory assessment in Morris water maze test. 5A: Effect of different treatments on time spent in the target zone. Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01).... by Atefeh Sadeghi (21253051)

“…<p><b> </b> Spatial memory assessment in Morris water maze test. 5A: Effect of different treatments on time spent in the target zone. Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01). …”

电针预处理通过心肌缺血损伤 棕色脂肪组织和 BMP3b/Smad1/5 通路小鼠 by Danying Qian (21730250)

Subjects: “…electroacupuncture significantly decreased…”

Box plots showing the taxa that were significantly different between thin and normal cows. by Bhuripit Saraphol (20855573)

Subjects:

Simulation datasets. by Xiao Mo (2430355)

“…Furthermore, the particle temperature decreases with smaller sizes. As the particle diameter rises from 10 μm to 100 μm, the minimum temperatures of the particles are 145 K and 264 K, respectively, indicating the need to match the particle diameter with the minimum temperature at which the drug particles remain effective. …”

ELISA analysis revealed a significant decrease in SP (A & B) and CGRP (C & D) protein levels in the corneas and tear fluid of mice treated with 0.5% bupivacaine (BUP) every alternate day for 15 days (administered via subconjunctival injection (SCI) alone or in combination with topical (TOP) application) compared to PBS-treated controls. by Ananya Datta (19932144)

Training impact on electrical properties of P3 lumbar MNs. Rin: input resistance. Rheobase: lowest intensity of current injected in MNs to elicit an action potential (AP). AP threshold: voltage measured at the foot of the AP. AP amplitude: measured between the resting membrane potential and the AP peak. AP half width: time spent by the potential > 50% of the AP maximum amplitude. AP rise time: time spent by the potential between 10% and 90% of the AP maximum amplitude. AP half decay time: time spent by the potential between the AP maximum amplitude and the 50% decreasing amplitude. ADP: after-depolarization potential.... by Camille Quilgars (21156495)

“…AP half decay time: time spent by the potential between the AP maximum amplitude and the 50% decreasing amplitude. ADP: after-depolarization potential. …”

<i>SLC2A2</i> is associated with IGF1R pathways differentiation. by Yejin Kim (740789)

Subjects:

Changes in <i>SLC2A2</i> gene expression in hepatocellular carcinoma (HCC) based on its stage and correlation with oncofetal and stemness genes. by Yejin Kim (740789)

Subjects:

<i>SLC2A2</i> is essential for liver differentiation in developing vertebrates by Yejin Kim (740789)

Subjects:

Primers used for qPCR gene expression analysis. by Yejin Kim (740789)

Subjects:

The IGF1R pathway is upregulated following <i>slc2a2</i> knockdown in HepG2 cells and zebrafish embryos. by Yejin Kim (740789)

Subjects:

Gene expression dynamics during liver development. by Yejin Kim (740789)

Subjects:

Protein levels of GLUT2 were analyzed by western blotting. by Yejin Kim (740789)

Subjects:

The (A) logistic regression model (LRM) and (B) random forest model (RFM) with only conservation scores as independent variables (orange, yellow) show decreased model fitting metri... by Bushra Haque (20513785)

EF-24 treatment significantly reduces cell viability in leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

The sequences of si-RNAs used in this study. by Changji Li (4806930)

Subjects:

Percent change in yearly crude rates (between 2019 and 2021 and between 2019 and 2024) by gender and state. by Tony Wong (779773)

Subjects:

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients.... by Emir Matpan (21655811)

“…<p>Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. …”

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

Subjects: